# Sentinel Lymph Node Biopsy in Rectal Cancer

> **NCT05830890** · NA · UNKNOWN · sponsor: **National Cancer Center, China** · enrollment: 87 (estimated)

## Conditions studied

- Rectal Cancer Stage III
- Rectal Cancer Stage IV

## Interventions

- **PROCEDURE:** Sentinel lymph node biopsy
- **DRUG:** Indocyanine green solution
- **DEVICE:** fluorescence laparoscope
- **DIAGNOSTIC_TEST:** pathological examination
- **DIAGNOSTIC_TEST:** rapid frozen pathological examination
- **PROCEDURE:** total mesorectal excision

## Key facts

- **NCT ID:** NCT05830890
- **Lead sponsor:** National Cancer Center, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2023-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05830890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05830890, "Sentinel Lymph Node Biopsy in Rectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05830890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*